AgeX Therapeutics, Inc.

AgeX Therapeutics, Inc.

AGE
AgeX Therapeutics, Inc.US flagNew York Stock Exchange Arca
11.10
USD
-1.50
- -
27.76MMarket Cap

AgeX Therapeutics, Inc. (AGE) Stock Split History

Learn about AgeX Therapeutics, Inc.'s most recent 100-for-3517 basis stock split on March 15, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about AgeX Therapeutics, Inc.'s most recent stock split

Split Date: 2024-03-15
Split Ratio: 100:3517
Price Before Split: $0.63
Price After Split: $0.02

Developer API

Get AGE split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/AGE

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 35.17 times fewer shares (a 100:3517 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of AgeX Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-03-15100:3517Yes$0.63$0.02
2015-05-0616:15NoN/AN/A
2014-05-0711:10NoN/AN/A
2012-05-045:4NoN/AN/A
2011-09-264:1NoN/AN/A

About AgeX Therapeutics, Inc.

Company overview and industry information

AgeX Therapeutics, Inc. (AGE) operates in the Biotechnology industry. The recent 100-for-3517 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to AgeX Therapeutics, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.